Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L, Schönknecht P, Ito K, Mielke R, Kalbe E, Zündorf G, Delbeuck X, Pelati O, Anchisi D, Fazio F, Kerrouche N, Desgranges B, Eustache F, Beuthien-Baumann B, Menzel C, Schröder J, Kato T, Arahata Y, Henze M, Heiss WD.

Neuroimage. 2002 Sep;17(1):302-16.

2.

Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI).

Haense C, Herholz K, Jagust WJ, Heiss WD.

Dement Geriatr Cogn Disord. 2009;28(3):259-66. doi: 10.1159/000241879. Epub 2009 Sep 25.

3.

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.

Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E, Sorbi S, Diehl-Schmid J, Perneczky R, Clerici F, Caselli R, Beuthien-Baumann B, Kurz A, Minoshima S, de Leon MJ.

J Nucl Med. 2008 Mar;49(3):390-8. doi: 10.2967/jnumed.107.045385. Epub 2008 Feb 20.

4.

PET studies in dementia.

Herholz K.

Ann Nucl Med. 2003 Apr;17(2):79-89. Review.

PMID:
12790355
5.

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.

Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A.

Neuroimage. 2008 Jan 15;39(2):619-33. Epub 2007 Sep 21.

PMID:
17962045
6.

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust WJ, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, DeKosky ST, Farlow MR, Gabel MJ, Higdon R, Kawas CH, Koeppe RA, Lipton AM, Foster NL.

Arch Neurol. 2011 Mar;68(3):329-37. doi: 10.1001/archneurol.2010.295. Epub 2010 Nov 8.

7.

18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.

Kerrouche N, Herholz K, Mielke R, Holthoff V, Baron JC.

J Cereb Blood Flow Metab. 2006 Sep;26(9):1213-21. Epub 2006 Mar 8.

PMID:
16525414
8.

Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.

Herholz K, Schopphoff H, Schmidt M, Mielke R, Eschner W, Scheidhauer K, Schicha H, Heiss WD, Ebmeier K.

J Nucl Med. 2002 Jan;43(1):21-6.

9.

Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.

Kawachi T, Ishii K, Sakamoto S, Sasaki M, Mori T, Yamashita F, Matsuda H, Mori E.

Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):801-9. Epub 2006 Mar 21.

PMID:
16550383
10.

(18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.

Mosconi L, Tsui WH, Pupi A, De Santi S, Drzezga A, Minoshima S, de Leon MJ.

J Nucl Med. 2007 Jul;48(7):1129-34. Epub 2007 Jun 15.

11.

Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease.

Mosconi L, Pupi A, De Cristofaro MT, Fayyaz M, Sorbi S, Herholz K.

J Nucl Med. 2004 Mar;45(3):382-92.

12.

FDG PET imaging in patients with pathologically verified dementia.

Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, Coleman RE.

J Nucl Med. 2000 Nov;41(11):1920-8.

13.

The Alzheimer's disease-related glucose metabolic brain pattern.

Teune LK, Strijkert F, Renken RJ, Izaks GJ, de Vries JJ, Segbers M, Roerdink JB, Dierckx RA, Leenders KL.

Curr Alzheimer Res. 2014;11(8):725-32.

PMID:
25212911
14.

Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.

Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE, Schwaiger M.

J Nucl Med. 2001 Apr;42(4):548-57.

15.

Evaluation of a new expert system for fully automated detection of the Alzheimer's dementia pattern in FDG PET.

von Borczyskowski D, Wilke F, Martin B, Brenner W, Clausen M, Mester J, Buchert R.

Nucl Med Commun. 2006 Sep;27(9):739-43.

PMID:
16894329
16.

Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer's disease: aging effect on diagnostic performance.

Matsunari I, Samuraki M, Chen WP, Yanase D, Takeda N, Ono K, Yoshita M, Matsuda H, Yamada M, Kinuya S.

J Nucl Med. 2007 Dec;48(12):1961-70. Epub 2007 Nov 15.

17.

Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison.

Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust WJ, Frisoni GB; EADC-PET Consortium, NEST-DD, and Alzheimer's Disease Neuroimaging Initiative.

J Nucl Med. 2012 Apr;53(4):592-600. doi: 10.2967/jnumed.111.094946. Epub 2012 Feb 17.

18.

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. Epub 2003 May 23.

PMID:
12764551
19.
20.

Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.

Ishii K, Kono AK, Sasaki H, Miyamoto N, Fukuda T, Sakamoto S, Mori E.

Eur J Nucl Med Mol Imaging. 2006 May;33(5):575-83. Epub 2006 Feb 10.

PMID:
16470370

Supplemental Content

Support Center